Medtronic (MDT) Common Equity (2014 - 2026)

Medtronic has disclosed Common Equity across 13 years of filings, most recently posting $50.8 billion for Q3 2026.

• In Q3 2026, Common Equity rose 5.64% year-over-year to $50.8 billion; the TTM figure through Jul 2026 stood at $50.8 billion (up 5.64% YoY), while the FY2026 annual figure was $50.1 billion, up 3.76% from the prior year.
• Common Equity came in at $50.8 billion for Q3 2026 at Medtronic, up from $50.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $52.8 billion in Q3 2022 to a low of $48.1 billion in Q3 2025.
• Average Common Equity over 5 years is $50.6 billion, with a median of $50.8 billion recorded in 2026.
• Year-over-year, Common Equity declined 6.24% in 2024 and grew 5.64% in 2026.
• Over 5 years, Common Equity stood at $52.1 billion in 2022, then fell by 0.79% to $51.6 billion in 2023, then declined by 5.68% to $48.7 billion in 2024, then increased by 0.29% to $48.9 billion in 2025, then rose by 4.08% to $50.8 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $50.8 billion in Q3 2026, $50.1 billion in Q2 2026, and $49.2 billion in Q1 2026.